Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim versus filgrastim with CHOP-14 + rituximab in elderly B-cell non-Hodgkin lymphoma
2005-004646-13Phase 2Completed
- Sponsor
- Policlinico Gemelli
- Start
- Apr 2007
- Modality
- Recombinant Proteins and Enzymes, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in non-Hodgkin lymphoma (NHL) comparing Pegfilgrastim arm with Filgrastim arm (2 arms). Primary endpoint: maintenance of dose intensity. Started Apr 2007; status: completed.
02
Drugs
pegfilgrastimfilgrastim
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on 2005-004646-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004646-13.